SCHEMBL9748435

SCHEMBL9748435

Nc1nc(-c2ccsc2)cs1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.59
RAB9A P51151 8/20 0.55
MAPT P10636 8/20 0.55
NPC1 O15118 7/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
LTA4H P09960 5/20 0.55
KDM4E B2RXH2 4/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55
RELA Q04206 2/20 0.55
CYP3A4 P08684 2/20 0.55
LMNA P02545 1/20 0.55
MKNK1 Q9BUB5 1/20 0.55
MKNK2 Q9HBH9 1/20 0.55
ALOX5 P09917 1/20 0.55
AR P10275 2/20 0.50
HSD17B10 Q99714 2/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1771825 0.80 ALDH1A1 (0.79) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL23610361 0.78 ALDH1A1 (0.83) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL10207991 0.78 GAA (0.51) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL6225037 0.76 EIF4E (0.46) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL172279 0.74 ALDH1A1 (0.70) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL44869 0.74 ALDH1A1 (1.00) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL130198 0.74 ALDH1A1 (0.69) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL10719025 0.74 ALDH1A1 (0.61) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL13714728 0.73 AR (0.51) ALDH1A1RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL29152977 0.73 NPC1 (0.60) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-57177060-A None JP disclosed
CN-117486872-A Mechanical ball milling synthesis method of aminothiazole compound 浙江工业大学 2024-02-02 CN disclosed
US-11453663-B2 Substituted propanamides as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2022-09-27 US disclosed
US-20220073507-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-03-10 US disclosed
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-07-08 US disclosed
CN-112351983-A Substituted propionamides as inhibitors of nucleases 马萨里克大学 2021-02-09 CN disclosed
EP-3556756-B1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2020-10-07 EP disclosed
EP-3556756-B1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2020-10-07 EP disclosed
WO-2019201867-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed
WO-2019201867-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed
EP-3556756-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed
EP-3556756-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed
US-5112362-A NAVY DYE MIXTURES OF AZO DISPERSE DYES FOR POLYESTER BASF AKTIENGESELLSCHAFT (DE) 1992-05-12 US disclosed
EP-0450434-A2 Marine blue dyestuff mixtures BASF Aktiengesellschaft (DE) 1991-10-09 EP disclosed
US-4841036-A COLORFAST, HEAT RESISTANCE MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1989-06-20 US disclosed
JP-S57177060-A DISAZO DYE FOR POLYESTER FIBER MITSUBISHI CHEM IND LTD 1982-10-30 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073507-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES DNASE1, RNASEH1, FEN1 ALDH1A1 1635/4885RAB9A 2621/4885MAPT 1351/4885
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME GAP43, NLN, SMN1; SMN2 ALDH1A1 1731/4885RAB9A 2420/4885MAPT 24/4885
US-11453663-B2 Substituted propanamides as inhibitors of nucleases DNASE1, RNASEH1, FEN1 ALDH1A1 1635/4885RAB9A 2621/4885MAPT 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.